Post-tonsillectomy hemorrhageMANAGEMENT

ENT AND MAXILLOFACIAL PRESENTATIONS · 12 SECTIONS

⚲

433 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

ENT and Maxillofacial Presentations27▾

Acute laryngitis Acute pharyngitis Auricular hematoma Bezold's Abscess Cerumen impaction Dry socket Ear foreign body Epistaxis (anterior)Epistaxis (Posterior)Labyrinthitis Ludwig's Angina Malignant Otitis Externa Marcus Gunn Pupil Mastoiditis Meniere's Disease Nasal Bone Fracture Nasal foreign body Nasal Septal Hematoma Otitis externa Otitis Media Post-tonsillectomy hemorrhage Sialolithiasis and sialadenitis Sinusitis Sudden Sensorineural Hearing Loss TMJ dislocation Tympanic membrane perforation Vestibular Neuronitis

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp62

Airway assessment and anticipated difficult airway

›Airway is the dominant hazard in this presentation

›Blood in the pharynx obscures direct and video laryngoscopy views

›Anticipate a difficult airway in every actively bleeding post-tonsillectomy patient

›Two working suction devices at the bedside before any airway attempt

›Rigid Yankauer plus a second suction line — single suction is inadequate for high-volume oropharyngeal blood

›ENT surgeon physically present for any airway attempt when available

›Surgeon can perform emergent bedside hemostasis or proceed directly to theatre if intubation fails

›Full stomach assumed — swallowed blood is a large-volume aspiration risk

›Rapid sequence intubation preferred over awake or sedation-only approaches

›Left lateral or head-down positioning during induction reduces aspiration risk if not actively bleeding into the airway

›Video laryngoscopy preferred first attempt

›Blood-soiled optics may still degrade view — have direct laryngoscopy and surgical airway backup ready

›Avoid blind instrumentation near the tonsillar fossa

›Blind nasopharyngeal airway, nasogastric tube, or deep blind suctioning can dislodge a stabilizing clot and precipitate massive rebleeding

›Airway compromise triggers

›Stridor or audible upper airway noise

›Inability to handle secretions or active hematemesis with altered mental status

›If airway compromise present, immediate airway team activation and RSI preparation

›Do not delay for imaging or laboratory results

Hemorrhage severity and hemodynamic assessment

›Hemorrhagic shock screening

›Blood pressure and heart rate

›Tachycardia is often the first and most reliable sign — hypotension is late

›SBP <90 mmHg or age-adjusted hypotension — decompensated hemorrhagic shock

›Children swallow blood — visible loss grossly underestimates true loss

›Tachycardia and repeated swallowing are the real signs of ongoing hemorrhage, not the volume seen in the mouth or on dressings

›A child who is repeatedly swallowing, restless, or pale should be treated as actively bleeding even without visible blood

›IV access — two large-bore peripheral IVs

›Fluid resuscitation initiated for any hemodynamic instability

›Type and crossmatch sent early — do not wait for confirmed major hemorrhage

›Serial reassessment

›Vital signs every 15 minutes during active or suspected ongoing hemorrhage

›Escalate to resuscitation bay for any hemodynamic deterioration

›Continuous pulse oximetry and cardiac monitoring

›Hypoxemia from aspirated blood or airway obstruction

ED temporizing measures and consultation triggers

›Positioning and local pressure while awaiting definitive care

›Sitting upright, leaning forward — spit blood, do not swallow, when the patient can cooperate

›Direct pressure on the tonsillar fossa with adrenaline-soaked gauze on Magill or bayonet forceps

›Gauze soaked in epinephrine 1:10,000 (100 mcg/mL), held firmly against the bleeding fossa for several minutes

›Requires direct visualization — do not apply blindly

›Nebulised or topical tranexamic acid as an adjunct while preparing for theatre

›Local hemostatic measures are temporizing only — they do not replace ENT evaluation

›ENT (urgent, not routine) for every case

›Any visible or reported post-tonsillectomy bleeding, including a bleed that has stopped by the time of arrival

›A herald bleed that has stopped still mandates ENT involvement and admission — this is not a discharge

›Anesthesia consultation in parallel for anticipated difficult airway

›Trismus, oropharyngeal edema, or inability to fully visualize the fossa

Key decision points — primary vs secondary bleed and herald bleed

›Primary (reactionary) hemorrhage

›Occurs within 24 hours of surgery

›Mechanism is a surgical vessel that failed to achieve hemostasis intraoperatively or slipped a ligature

›Higher rate of return to theatre than secondary bleeding

›Secondary (delayed) hemorrhage

›Typically day 5 to 10 postoperatively, can occur up to approximately day 14

›Mechanism is eschar separation from the tonsillar bed as the surgical wound heals

›Often provoked by dietary indiscretion, dehydration, or superimposed infection loosening the eschar prematurely

›The timing distinction changes disposition and the anticipated re-bleed trajectory, not the acuity of the initial response

›Secondary bleeds can still be massive and airway-threatening despite the "delayed" label

›Herald bleed

›A small, self-limited bleed that precedes a major hemorrhage in a meaningful proportion of cases

›Represents transient exposure of the vessel before full eschar separation or clot dislodgement

›Management is identical regardless of whether bleeding is ongoing on arrival

›ENT evaluation and admission for observation are mandatory even when bleeding has fully stopped and the patient looks well

›Discharge after a reported herald bleed without ENT assessment is a sentinel error in this presentation

02History/hx37

Timing since tonsillectomy

›Postoperative day

›Exact number of days since surgery

›Within 24 hours — primary hemorrhage pattern

›Day 5 to 10 — secondary hemorrhage pattern, eschar separation

›Indication for original tonsillectomy

›Recurrent tonsillitis, peritonsillar abscess, or obstructive sleep apnea

›Surgical technique if known

›Cold steel dissection versus electrocautery or coblation — technique influences eschar behavior and secondary bleed timing

Bleeding characteristics and herald bleed

›Description of the bleeding episode

›Onset, duration, and whether ongoing at time of arrival

›Spontaneous versus provoked by coughing, retching, or eating

›Estimated volume and number of discrete episodes

›Small streaks of blood-tinged saliva versus frank hemorrhage

›History of a prior small bleed that has now stopped

›Herald bleed — treat as mandating ENT evaluation and admission regardless of current appearance

›Prior presentation for bleeding since surgery

›Recurrent presentations increase concern for an unstable clot or an undiagnosed bleeding disorder

Occult blood loss and swallowed blood

›Swallowed blood indicators

›Repeated swallowing, gulping, or throat clearing

›In children this may be the only visible sign of ongoing hemorrhage

›Hematemesis or coffee-ground emesis

›Represents swallowed blood, not a new upper GI source, in this clinical context

›Restlessness, pallor, or behavior change in a young child

›May precede measurable vital sign change

›Oral intake and hydration

03Physical Exam/exam38

Vital signs and hemodynamic assessment

›Vital sign interpretation

›Heart rate relative to age-specific normal range

›Young children have higher resting heart rates — a "normal-looking" rate may already reflect compensated shock

›Tachycardia out of proportion to fever or distress — treat as hemorrhage until proven otherwise

›Blood pressure

›Hypotension is a late finding, especially in children — normal blood pressure does not exclude significant blood loss

›Respiratory rate and oxygen saturation

›Tachypnea or desaturation from aspirated blood or airway compromise

Oral cavity and tonsillar fossa exam

›Direct visualization of the tonsillar fossae

›Good lighting, suction immediately available before examination

›Active bleeding point, clot, or eschar disruption

›Clot in the tonsillar fossa

›Do not disturb or probe an adherent clot — risk of precipitating rebleeding

›Fresh blood pooling in the posterior oropharynx

›Suggests ongoing hemorrhage even without a visible active point

›Airway examination

›Trismus or limited mouth opening

›Limits both examination and any airway intervention

›Oropharyngeal edema or distortion

›Anticipate difficult laryngoscopy

Signs of occult hemorrhage

›Indirect evidence of blood loss

›Pallor

›Cool, mottled extremities — poor perfusion

›Repeated swallowing observed during the examination

›The single most useful bedside sign of ongoing hemorrhage in a young child who cannot report symptoms

04Differential Diagnosis/ddx24

Tonsillectomy hemorrhage classification

›Primary (reactionary) hemorrhage

›Within 24 hours of surgery — surgical vessel or slipped ligature

›Secondary (delayed) hemorrhage

›Day 5 to 10, up to approximately day 14 — eschar separation from the healing tonsillar bed

›Herald (sentinel) bleed

›Self-limited bleeding preceding a major hemorrhage — mandates the same evaluation as active bleeding

›Coding

›ICD-10 T81.0XXA — hemorrhage and hematoma complicating a procedure, not elsewhere classified, initial encounter

›Commonly used general code for postprocedural hemorrhage in this context

›SNOMED CT concept for postoperative hemorrhage following tonsillectomy

Mimics and alternative bleeding sources

›Sources that mimic tonsillar fossa hemorrhage

›Epistaxis with blood draining into the oropharynx

›Anterior rhinoscopy to exclude a concurrent nasal source

›Gingival or dental bleeding

›Localized inspection distinguishes from the tonsillar fossa

›Swallowed blood re-presenting as hematemesis without an active oral source

›Repeat oral exam to confirm the fossa is not actively bleeding before attributing emesis solely to swallowed blood

Associated airway and systemic complications

›Complications that change management

›Aspiration of blood

›Hypoxemia, cough, or respiratory distress out of proportion to visible bleeding

›Hemorrhagic shock

›Tachycardia, delayed capillary refill, altered mental status

›Unmasked bleeding disorder

›Disproportionate or recurrent bleeding for the described injury — send coagulation workup

05Laboratory Tests/lt19

Hemorrhage and coagulation assessment

›Complete blood count

›Hemoglobin and hematocrit

›Initial value may be falsely reassuring in acute hemorrhage — hemodilution has not yet occurred

›Serial measurement more useful than a single value in ongoing or recurrent bleeding

›Platelet count

›Baseline for transfusion planning and to screen for an occult platelet disorder

›Coagulation studies

›PT/INR and aPTT

›Usually normal — this is a surgical bleed, not primarily a coagulopathic process

›Do not delay ENT evaluation or theatre while awaiting coagulation results in an actively bleeding patient

›Fibrinogen if massive transfusion anticipated

›Trends with ongoing consumption and dilution during large-volume resuscitation

Blood typing and transfusion prep

›Type and crossmatch

›Sent early for any more than minimal bleeding

›Do not wait for hemodynamic instability to be confirmed before sending

›Uncrossmatched O-negative blood available for life-threatening ongoing hemorrhage while crossmatch is pending

›Venous blood gas and lactate

›Lactate as a marker of hypoperfusion when clinical assessment is equivocal

›Ionized calcium if massive transfusion is underway

06Diagnostic Tests/dt23

Scoring Systems

›Clinical scoring

›No validated ED triage or severity score exists specifically for post-tonsillectomy hemorrhage

›Severity is judged clinically — volume, hemodynamics, and airway status

›Shock Index (heart rate divided by systolic blood pressure) as a general adjunct

›Greater than 1.0 suggests significant hemorrhage

›Greater than 1.5 suggests major hemorrhage with likely transfusion requirement

MRI

›MRI role

›No role in the acute evaluation of post-tonsillectomy hemorrhage

›Too slow for a time-critical bleeding and airway presentation

›Occasionally used later for suspected pseudoaneurysm or vascular injury when the diagnosis is unclear and the patient is stable

›CT role

›Not indicated for the initial evaluation of a bleeding or recently bled tonsillar fossa

›Diagnosis is clinical, made by direct visualization

›CT angiography of the neck

›Reserved for suspected pseudoaneurysm of the external carotid or lingual/facial artery branches after recurrent or unexplained bleeding

›Only obtained once the patient is stabilized — never in place of urgent ENT evaluation for active bleeding

›Limitations

›Radiation exposure in a predominantly pediatric population

›Does not substitute for direct airway and source assessment

Ultrasound

›Ultrasound role

›No primary diagnostic role for localizing the tonsillar fossa bleeding source

›Point-of-care cardiac and IVC assessment

›Adjunct for fluid responsiveness in a patient with hemorrhagic shock and equivocal vital signs

07Disposition/dispo25

Admission and observation criteria

›Admission required for essentially all patients

›Any confirmed active bleeding, regardless of volume

›Any herald bleed that has stopped by the time of evaluation

›A stopped bleed with a normal exam is still an admission, not a discharge

›Minimum observation period per ENT assessment, typically at least overnight

›Rebleeding risk persists for the following 24 to 48 hours after any bleeding episode

Operative (theatre) criteria

›Return to theatre

›Active hemorrhage not controlled by ED temporizing measures

›Definitive hemostasis is achieved in theatre under general anesthesia, not in the ED

›Recurrent bleeding after an initial episode, even if each individual episode is small

›Any bleeding with airway compromise

›Combined airway securing and surgical hemostasis performed together

ICU-level care

›ICU admission triggers

›Hemorrhagic shock requiring large-volume resuscitation or vasopressor support

›Airway compromise requiring intubation

›Postoperative ventilatory monitoring until extubation criteria met and ENT clears the airway

›Massive transfusion protocol activation

Discharge and transfer criteria

›Discharge is exceptional, not routine, in this diagnosis

›Only after direct ENT evaluation confirms no active bleeding, no herald bleed history, and a benign fossa exam

›ED clinicians should not discharge a suspected or reported post-tonsillectomy bleed without ENT input

›Reliable caregiver, close proximity to a facility with ENT and operative capability, and clear return precautions

›Transfer

›Facility without on-site ENT or pediatric anesthesia capability

›Transfer before deterioration — arrange emergently once any bleeding is confirmed or a herald bleed is reported

08Treatment/t118

Airway management

›Preparation before any airway intervention

›Two working suction devices, video laryngoscope, and surgical airway equipment at the bedside

›ENT surgeon present or immediately available

›Rapid sequence intubation preferred for a patient with active bleeding and a presumed full stomach

›Ketamine 1 to 2 mg/kg IV induction — preserves airway reflexes and hemodynamic stability, favored in hemorrhagic shock

›Verify against current pediatric guideline before use

›Rocuronium 1.2 mg/kg IV for rapid, reliable paralysis

›Verify against current pediatric guideline before use

›Avoid or reduce the dose of hypotension-prone induction agents (propofol) in a hypovolemic patient

›If intubation attempt fails, proceed immediately to surgical airway or emergent transfer to theatre per difficult airway pathway

›Do not repeat multiple failed attempts with a soiled, obscured airway

Local hemostatic measures

›Direct pressure

›Adrenaline-soaked gauze on Magill or bayonet forceps applied directly to the visualized bleeding point

›Epinephrine 1:10,000 (100 mcg/mL) soaked gauze, firm sustained pressure for several minutes

›Systemic absorption risk — monitor for tachyarrhythmia, especially in children and with repeated application

›Silver nitrate cautery to a discrete, actively oozing point

›Only under direct visualization by an experienced clinician or ENT — not a routine ED first step on a fresh surgical bed

›Limitations of ED local measures

›Temporizing only — do not repeat failed local measures indefinitely while a patient continues to bleed

›Escalate to theatre if bleeding is not controlled promptly with initial local measures

Tranexamic acid

›Systemic tranexamic acid

›Adult dosing

›1 g IV over 10 minutes

›May repeat once if bleeding continues, guided by ENT and ongoing hemorrhage

›Dosing extrapolated from trauma hemorrhage protocols — dedicated post-tonsillectomy hemorrhage trial evidence is limited

›Pediatric dosing

›15 mg/kg IV (maximum 1 g) over 10 minutes

›Verify against current pediatric guideline before use

›May repeat once for continued bleeding at ENT direction

›Verify against current pediatric guideline before use

›Contraindications and cautions

›History of seizure disorder — dose-related seizure risk with rapid or high-dose administration

›Renal impairment — dose adjustment required, renally cleared

›Active thromboembolic disease — relative contraindication

›Topical and nebulised tranexamic acid

›Topical tranexamic acid 500 mg diluted in 5 mL normal saline

›Soaked gauze applied directly to the tonsillar fossa as an adjunct to direct pressure

›Nebulised tranexamic acid 500 mg in 5 mL normal saline nebulised over 10 to 15 minutes

›Adjunct while awaiting ENT and theatre availability — does not replace definitive control

Fluid and blood product resuscitation

›Crystalloid resuscitation

›Adult — isotonic crystalloid bolus, reassess after each bolus and titrate to hemodynamic response

›Pediatric — 10 to 20 mL/kg isotonic balanced crystalloid IV bolus over 10 to 20 minutes

›Verify against current pediatric guideline before use

›Reassess after each bolus; deceleration to smaller volumes or earlier transition to blood products if response is inadequate or hemorrhage is ongoing

›Because visible blood loss underestimates true loss in children, resuscitate to clinical response (heart rate, perfusion, mental status), not to the volume of blood seen

›Large-volume crystalloid without blood products risks dilutional coagulopathy in major hemorrhage — transition early to blood products rather than repeated crystalloid boluses

›Blood product transfusion

›Adult — packed red blood cells, reassess hemoglobin and hemodynamics after each unit

›Transfusion threshold individualized; transfuse for hemodynamic instability with active bleeding regardless of a single hemoglobin value

›Pediatric — packed red blood cells 10 mL/kg (range 10 to 20 mL/kg) IV

›Verify against current pediatric guideline before use

›Uncrossmatched O-negative blood for life-threatening ongoing hemorrhage while crossmatch is pending

›Rate guided by hemodynamic severity — more rapid administration for decompensated shock

›Massive transfusion protocol

›Activate for ongoing hemorrhage with hemodynamic instability unresponsive to initial crystalloid and first blood products

›Balanced ratio of red cells, plasma, and platelets per local massive transfusion protocol

›Rapid or large-volume transfusion monitoring

›Ionized calcium — citrate-induced hypocalcemia with rapid transfusion

›ECG monitoring for QT prolongation from hypocalcemia and for hyperkalemia-related changes with large-volume or older-unit transfusion

›Calcium replacement for symptomatic or significant hypocalcemia during massive transfusion

Antiemetic therapy and analgesia

›Antiemetics

›Ondansetron

›Adult 4 mg IV once, may repeat

›Pediatric 0.15 mg/kg IV (maximum 4 mg) once, may repeat

›Verify against current pediatric guideline before use

›Vomiting and retching raise venous and pharyngeal pressure and can dislodge a stabilizing clot — active antiemetic control is a hemostatic measure, not just comfort

›Analgesia

›Paracetamol (acetaminophen)

›Adult 1000 mg PO or IV every 6 hours, maximum 4000 mg per day

›Pediatric 15 mg/kg PO or IV every 4 to 6 hours, maximum single dose 1000 mg, maximum 4 doses per 24 hours

›Verify against current pediatric guideline before use

›First-line analgesic in the actively bleeding or recently bled patient

›Avoid NSAIDs and aspirin during active or recent bleeding

›Antiplatelet effect can worsen or precipitate hemorrhage — hold regardless of the broader post-tonsillectomy NSAID debate in uncomplicated recovery

›Opioids for severe pain only, with caution

›Sedation can blunt airway protective reflexes and mask evolving hemodynamic compromise — use the lowest effective dose with close monitoring

›Codeine is contraindicated in children after tonsillectomy — boxed warning for rare but fatal respiratory depression in ultra-rapid CYP2D6 metabolizers

›Tramadol carries the same metabolizer-related caution and is avoided in this population

Anticoagulation and antiplatelet management

›General principle

›Hold any anticoagulant or antiplatelet agent the patient is taking during active or recent hemorrhage

›Confirm timing and dose of last exposure

›Reversal only for significant hemorrhage in a patient on therapeutic anticoagulation, in consultation with hematology

›4-factor prothrombin complex concentrate for warfarin reversal, dosed by INR per institutional protocol

›Idarucizumab for dabigatran reversal, andexanet alfa or 4-factor prothrombin complex concentrate for factor Xa inhibitor reversal when specific reversal is unavailable

›This scenario is uncommon in the predominantly pediatric tonsillectomy population but relevant in adolescent or adult patients on chronic anticoagulation

Iatrogenic harms in routine ED care

›Intubation

›Hazardous in this population — blood-obscured view, aspiration risk from a full stomach of swallowed blood, and risk of dislodging a clot during oropharyngeal instrumentation

›Requires RSI, two suctions, video laryngoscopy, and surgeon presence as above — not a routine or delegated procedure

›Sedation

›Any sedation blunts airway protective reflexes in a patient with active oropharyngeal bleeding and a full stomach

›Reserve for controlled settings with full airway equipment and personnel present; avoid incidental procedural sedation before ENT and anesthesia involvement

›Fluid loading

›Indicated for hypovolemia but must not substitute for blood product transfusion in major hemorrhage

›Under-resuscitation results from trusting visible blood loss alone; over-resuscitation with crystalloid alone dilutes clotting factors

›Oxygen

›Supplemental oxygen by simple face mask or nasal cannula is appropriate and safe

›Avoid bag-valve-mask ventilation where possible — positive pressure risks gastric insufflation and vomiting of swallowed blood with aspiration

›Vasopressors

›Not a substitute for volume and blood product replacement

›Masks ongoing hypovolemia and can delay recognition of inadequate resuscitation; reserve for peri-intubation hypotension as a bridge, not as primary therapy

›Mechanical circulatory support

›Not applicable to this diagnosis

›Intra-aortic balloon pump and other mechanical circulatory support have no role — this is a surgical bleeding source, not a cardiac pump failure process

›Anticoagulation

›Contraindicated during active or recent hemorrhage

›Hold any therapeutic or prophylactic anticoagulant regardless of the original indication until hemostasis is secured

›Fibrinolysis

›Thrombolytic (fibrinolytic) therapy is contraindicated — it would worsen hemorrhage

›Do not confuse with the antifibrinolytic tranexamic acid, which is indicated and is the opposite mechanism

›Analgesia

›NSAIDs, aspirin, codeine, and sedating opioid doses each carry a specific hazard in this diagnosis as detailed above

›Paracetamol is the default safe first-line agent

Definitive surgical control

›Theatre-based hemostasis

›Definitive control is achieved in theatre under general anesthesia by ENT — suture ligation, cautery, or re-exploration of the tonsillar fossa

›All ED measures are temporizing; do not delay operative care while repeating failed local measures

›Combined airway securing and surgical hemostasis for any patient with airway compromise

›Postoperative monitoring after return to theatre

›Observation for recurrent bleeding for at least 24 hours after operative control

09Special Populations/sp28

Pregnancy

›Pregnancy considerations

›Tonsillectomy is uncommon in pregnancy and post-tonsillectomy hemorrhage in a pregnant patient is rare

›General hemorrhage and airway management principles above apply unchanged

›Positioning — left lateral tilt or left lateral decubitus if advanced pregnancy, to avoid aortocaval compression during resuscitation

›Imaging and medication selection

›Avoid CT unless maternal benefit clearly outweighs fetal radiation risk

›Tranexamic acid — no specific pregnancy contraindication for short-term hemorrhage control; use per hemorrhage severity

›Obstetric consultation for any significant maternal hemorrhage

Geriatric

›Older adult considerations

›Adult and older tonsillectomy patients (post-surgical for malignancy work-up, sleep apnea, or recurrent tonsillitis) have less physiologic reserve for blood loss

›Earlier hemodynamic decompensation for the same volume of hemorrhage

›Comorbidities affecting management

›Anticoagulant or antiplatelet use is more prevalent — see anticoagulation management above

›Cardiac disease — cautious but adequate volume resuscitation, do not under-resuscitate an actively bleeding patient out of fluid-restriction habit

›Beta-blocker use may blunt the compensatory tachycardia that would otherwise signal hemorrhage

Pediatrics

›Pediatric-specific considerations

›This is predominantly a pediatric diagnosis — tonsillectomy is common in childhood for obstructive sleep apnea and recurrent tonsillitis

›Visible blood loss grossly underestimates true loss — swallowed blood is the dominant hidden compartment

›Repeated swallowing, restlessness, and tachycardia are the key signs, often present before any measurable hypotension

›Weight-based resuscitation

›Document weight in kilograms for every dose

›Fluid bolus, tranexamic acid, blood product volume, antiemetic, analgesic, and RSI induction doses are all weight-based as detailed in Treatment

›Verify against current pediatric guideline before use for every resuscitation dose listed above

›Undiagnosed bleeding disorder

›Recurrent or disproportionate post-tonsillectomy bleeding may be the first presentation of von Willebrand disease or a platelet disorder — send coagulation and hematology workup

10Background/b22

Epidemiology

›Incidence

›Primary (reactionary) hemorrhage incidence approximately 0.2 to 2.2 percent

›Secondary (delayed) hemorrhage incidence approximately 0.1 to 3 percent, peak onset day 5 to 10

›Overall return-to-theatre rate for hemorrhage approximately 0.5 to 1 percent across large series

›Mortality is rare, historically estimated at roughly 1 in 30,000 to 40,000 tonsillectomies, with figures varying across national audits and eras

›Age and technique associations

›Older children and adolescents have higher reported secondary hemorrhage rates than young children

›Electrocautery and coblation techniques have been associated in some series with different secondary bleed timing and rate compared with cold steel dissection

Pathophysiology

›Wound healing mechanism

›The tonsillar fossa heals by secondary intention, covered by a fibrinous eschar

›Primary hemorrhage — inadequate intraoperative hemostasis of a named vessel or slipped ligature

›Secondary hemorrhage — eschar separation as granulation tissue replaces it around day 5 to 10, exposing underlying vessels

›Vascular supply of the tonsillar fossa

›Branches of the external carotid system — tonsillar, ascending pharyngeal, facial, and lingual artery branches

›Provoking factors for secondary bleeding

›Local infection, dehydration, dietary trauma to the healing bed, and vigorous coughing or straining

Therapeutic Considerations

›Rationale for the herald bleed rule

›A self-limited bleed reflects transient vessel exposure before the eschar or clot has stabilized — the underlying vessel remains exposed and can rebleed at any time, including massively, which is why observation and ENT evaluation are mandatory even when bleeding has stopped

›Rationale for antifibrinolytic use

›Tranexamic acid stabilizes clot by inhibiting fibrinolysis at the wound surface, an adjunct while definitive surgical control is arranged, extrapolated from broader hemorrhage evidence rather than a large dedicated post-tonsillectomy trial base

›Rationale for early blood product transition

›Because true blood loss (largely swallowed) exceeds visible loss, resuscitation guided by clinical signs rather than visible volume avoids under-treatment, and early blood product use avoids dilutional coagulopathy from crystalloid-only resuscitation

11Patient Discharge Instructions/pdi19

copy discharge instructions

›You were evaluated for bleeding after tonsil surgery

›Bleeding after tonsil surgery, even a small amount that has stopped, needs to be checked by an ear, nose, and throat (ENT) specialist and monitored in hospital

›These instructions apply if your ENT team and the emergency department have specifically told you that you are safe to go home

›Medications

›Take paracetamol (acetaminophen) as directed for pain — adult 1000 mg by mouth every 6 hours, maximum 4000 mg per day; children 15 mg per kg by mouth every 4 to 6 hours as directed by your care team

›Do not take aspirin, ibuprofen, or other anti-inflammatory pain medicines unless your care team specifically approves them

›Do not give codeine or tramadol to a child for pain after tonsil surgery

›Diet and activity

›Soft, cool foods and adequate fluids to keep the healing area moist and avoid straining

›No vigorous coughing, straining, nose blowing, or strenuous activity for the time period your ENT team specifies

›Return to the emergency department immediately if

›Any new bleeding from the mouth or throat, even a small amount

›Repeated swallowing, spitting up blood, or vomiting blood or dark material

›Difficulty breathing, noisy breathing, or trouble handling spit or saliva

›Fast heart rate, dizziness, fainting, or looking unusually pale

›Fever above 38.5 degrees Celsius

›Follow-up

›ENT follow-up appointment as arranged before discharge

›Do not miss this appointment even if you feel well

12References/r18

Guidelines and key sources

›Mitchell RB et al — Clinical Practice Guideline: Tonsillectomy in Children (Update) — Otolaryngology–Head and Neck Surgery 2019

›American Academy of Otolaryngology–Head and Neck Surgery guideline

›Strong recommendation to counsel caregivers on postoperative hemorrhage warning signs and the need for immediate evaluation

›Frerk C et al — Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults — British Journal of Anaesthesia 2015

›General difficult airway principles applied to a blood-obscured, high-aspiration-risk airway

›Two-suction, video-laryngoscopy-first, surgical-backup approach

›SIGN 117 — Management of Sore Throat and Indications for Tonsillectomy — Scottish Intercollegiate Guidelines Network 2010

›National guideline addressing tonsillectomy indications and perioperative complication management

Landmark studies and additional sources

›Windfuhr JP, Chen YS, Remmert S — Hemorrhage following tonsillectomy and adenoidectomy in 15,218 patients — Otolaryngology–Head and Neck Surgery 2005

›Large single-center series characterizing primary versus secondary hemorrhage rates and timing

›Sarny S et al — Hemorrhage following tonsil surgery: a multicenter prospective study — Laryngoscope 2011

›Austrian multicenter prospective audit of tonsillectomy hemorrhage rates and risk factors

›National Prospective Tonsillectomy Audit — Royal College of Surgeons of England, 2003–2005

›Large UK national audit reporting hemorrhage and return-to-theatre rates

›Shakur H et al, CRASH-2 trial collaborators — Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients — Lancet 2010

›Landmark trial establishing tranexamic acid hemorrhage-control evidence extrapolated to other bleeding presentations

›US Food and Drug Administration — Boxed warning restricting codeine and tramadol use in children after tonsillectomy and/or adenoidectomy — 2013 (codeine), 2017 (tramadol)

›Basis for the pediatric analgesia contraindication in this file

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed September 13, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.